Overlapping Approach of Proton Pump Inhibitors/Nux vomica-Heel as New Intervention for GERD Management

The Delphi Consensus presents an innovative approach to GERD treatment by combining Proton Pump Inhibitors (PPIs) with Nux vomica-Heel. This strategy aims to gradually reduce PPI use while managing symptoms effectively. It suggests starting with both PPIs and Nux vomica-Heel, then tapering off the PPIs, helping maintain symptom control with fewer side effects. This dual approach offers a promising solution for long-term GERD management, addressing both efficacy and safety concerns associated with prolonged PPI use.

References: https://www.wjgnet.com/1007-9327/full/v30/i18/2467.htm